Respiratory diseases will worsen with global climate change
Worldwide increases in the incidences of asthma, allergies, infectious and cardiovascular diseases will result from a variety of impacts of global climate change,
Worldwide increases in the incidences of asthma, allergies, infectious and cardiovascular diseases will result from a variety of impacts of global climate change,
Troublesome dyspnoea that limits sexual activity is common among older patients with COPD, according to a new study from Denmark.
Poorly managed pain in the neonatal intensive care unit has serious short- and long-term consequences, causing physiological and behavioral instability in preterm infants and long-term changes in their… read more.
Tel Aviv University develops BL-7050 to ease the neuropathic pain of millions of sufferers.
by Dr Sunil Upadhyay – There is clear evidence that the USA spends twice as much as any other country per GDP on cancer treatment but, except for… read more.
by Dr Sunil Upadhyay – Age is the number one risk factor for the development of breast cancer. Not only the incidence but also the mortality from breast… read more.
by Dr Alison Louise Jones (pictured) – The headline figures are that the majority of women survive a diagnosis of breast cancer: 78% of those women currently diagnosed… read more.
The difficulties that many women describe as memory problems when menopause approaches are real, according to a study published today in the journal Menopause, the journal of the… read more.
In Europe, osteoporotic fractures account for more Disability Adjusted Life Years (DALYs) lost than common cancers with the exception of lung cancer.
Support is growing for increased collaboration between pharmaceutical companies and patients in research processes worldwide, according to a new report by healthcare intelligence company GBI Research.
A study of discontinuing natalizumab for multiple sclerosis patients testing positive for JC virus antibody found a higher relapse rate within 6 months than for patients continuing the… read more.
New guidelines on dyslipidemia and the prevention of atherogenesis give official sanction to something endocrinologists have been doing for years: lowering LDL targets.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.